The firm said it would focus resources on other late-stage programs after a Phase III study showed little survival benefit on first-line bemarituzumab.

Company to Participate in BIO Partnering Summit and Present Phase 1 Ketamir-2 Data at American Association for Cancer ...

PF'3944 is an ultra-long-acting fully biased GLP-1 receptor agonist (RA). It is being developed as a single agent weekly and as a monthly therapy, and in combination with various peptides including an ...

Altimmune, Inc. closed a $75 million direct offering to fund Phase 3 pemvidutide trials for MASH. Learn more about ALT stock here.

Allakos Inc. announced that its phase 1 trial of AK006 for chronic spontaneous urticaria (CSU) did not show therapeutic efficacy, leading the company to discontinue its development. While AK006 was ...

Construction has started on the second phase of the two-phase Somos at McLean Metro, an affordable housing development backed by Amazon.com, SCG Development, a Tysons real estate developer, announced ...

Targeting Ore Reserves, PFS and ML application by the end of 2026HIGHLIGHTSMay 2025 Optimised Scoping Study (OSS) ...

A Zionsville-based developer is preparing for the next phase of development at a 48-acre residential and commercial project along Michigan Road in Zionsville. Pittman Partners plans to build up to 225 ...

Highlighting Siddharthnagar’s transformation, CM Yogi said that eight to ten years ago, the presence of a medical college in ...

The European Union’s declaration establishes binding timelines to restrict Russian pipeline and LNG imports, reinforcing the ...

JPI has broken ground on Portico, a previously announced 272-unit multifamily project with 18,841 square feet of ground-level ...